Observational Trial of Antibiotic-Coated Central Venous Catheters in Critically Ill Pediatric Patients
暂无分享,去创建一个
S. Coffin | C. Feudtner | T. Zaoutis | L. Bell | T. Dominguez | K. Heydon | A. Chelliah | Sujata M Patil | K. S. St John | Susan Rettig | Richard Lin | Anjali Chelliah
[1] C. Hollenbeak,et al. Attributable Cost of Nosocomial Primary Bloodstream Infection in Pediatric Intensive Care Unit Patients , 2005, Pediatrics.
[2] J. Rello,et al. Benefits of minocycline and rifampin-impregnated central venous catheters , 2004, Intensive Care Medicine.
[3] D. Maki,et al. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Rupp,et al. Prevention of central venous catheter-related bloodstream infections , 2004 .
[5] G. Samonis,et al. Clinical Experience With Minocycline and Rifampin-Impregnated Central Venous Catheters in Bone Marrow Transplantation Recipients: Efficacy and Low Risk of Developing Staphylococcal Resistance , 2003, Infection Control & Hospital Epidemiology.
[6] S. Tambe,et al. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. , 2001, The Journal of antimicrobial chemotherapy.
[7] A. Slonim,et al. The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit , 2001, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[8] L. Mermel,et al. New technologies to prevent intravascular catheter-related bloodstream infections. , 2001, Emerging infectious diseases.
[9] A. Costarino,et al. The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit , 2001, Critical care medicine.
[10] Sanjay Saint,et al. Prevention of Intravascular Catheter-Associated Infections , 2001 .
[11] ohn,et al. A COMPARISON OF TWO ANTIMICROBIAL-IMPREGNATED CENTRAL VENOUS CATHETERS , 2000 .
[12] S. Saint,et al. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. , 1999, JAMA.
[13] D. Morck,et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. , 1998, Critical care medicine.
[14] Rabih Darouiche,et al. Central Venous Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter-Related Colonization and Bloodstream Infections , 1997, Annals of Internal Medicine.
[15] A. Gabrielli,et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. , 1997, Annals of internal medicine.
[16] F. Moler,et al. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complications. , 1990, Critical care medicine.
[17] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[18] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.